Blue Cap AG, a Munich-based investment company focused on acquiring and developing medium-sized B2B businesses, has announced a significant change to its Management Board. Dr. Henning von Kottwitz, Chairman of the Management Board, will leave the company effective at the end of October 8, 2026, following a mutual agreement with the Supervisory Board. The Supervisory Board expressed its gratitude for his service and commitment, noting that Blue Cap AG is well positioned for further development, particularly due to the transactions implemented in recent years under his leadership. This leadership transition comes at a crucial time for the company, which pursues a Buy-Transform-Sell strategy and holds majority stakes in six portfolio companies across plastics engineering, production engineering, pre-press solutions, life sciences, and business services.
To ensure continuity and drive the next phase of growth, the Supervisory Board has resolved to second its Chairman, Dr. Christian Diekmann, to the Management Board as a member with effect from October 9, 2026, pursuant to Section 105(2) of the German Stock Corporation Act (AktG). Dr. Diekmann will be responsible for strategy and finance. He has served as Chairman of the Supervisory Board since 2024 and brings extensive experience in operational restructuring and the management of medium-sized corporate groups. His previous roles include CEO of the listed Max Automation SE and CFO of the family-owned Zertus Group. Henning Eschweiler will remain a member of the Management Board as COO and continue to oversee operational portfolio management. Additionally, effective October 9, 2026, he will assume responsibility for M&A. This internal reshuffle underscores the company's commitment to leveraging its deep bench of talent and maintaining strategic momentum.
The implications of this announcement are significant for Blue Cap AG and its stakeholders. Dr. Diekmann's move from the Supervisory Board to the Management Board is a notable governance event, as it blurs the traditional separation between oversight and executive functions. However, it also signals a hands-on approach to steering the company through a challenging economic environment. As Dr. Michael Schieble, Deputy Chairman of the Supervisory Board, stated, "We are very pleased that Dr Christian Diekmann has agreed to drive the further development of Blue Cap AG’s business model as a member of the Management Board in the near term and take it to the next level. As Chairman of the Supervisory Board, he has in-depth knowledge of Blue Cap and understands its potential as a listed investment company pursuing the successful Buy-Transform-Sell strategy." Dr. Diekmann himself added, "Blue Cap AG is ideally positioned as an investor in ‘special situations’ to grow in the current economic environment. Many companies that are fundamentally well positioned for the future are increasingly affected by disruptions in industry and structural challenges. We aim to address these challenges through our business model, strengthen Germany as an industrial location and create value for our shareholders." His comments highlight the company's focus on navigating structural disruptions and supporting the German industrial landscape, which could have broader economic resonance.
Blue Cap AG, founded in 2006, acquires medium-sized B2B companies in special situations, typically with revenues between EUR 20 million and EUR 200 million, and supports their development with the goal of profitable divestment. The Group employs around 2,000 people across Germany, Europe, North America, and Asia. Its shares trade on the Open Market (Scale, Frankfurt, and m:access, Munich; ISIN: DE000A0JM2M1; ticker symbol: B7E). For more information, visit www.blue-cap.de. The original release can be viewed on www.newmediawire.com, as distributed by NEWMEDIAWIRE.
